Cargando…

STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice

BACKGROUND: Myeloid-derived suppressor cells (MDSCs) represent a negative prognostic factor in malignant melanoma. These cells are generated under chronic inflammatory conditions typical of cancer. The transcription factor signal transducer and activator of transcription 3 (STAT3) orchestrates MDSC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bitsch, Rebekka, Kurzay, Annina, Özbay Kurt, Feyza, De La Torre, Carolina, Lasser, Samantha, Lepper, Alisa, Siebenmorgen, Alina, Müller, Verena, Altevogt, Peter, Utikal, Jochen, Umansky, Viktor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Basic Tumor Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932276/ https://www.ncbi.nlm.nih.gov/pubmed/35301236 http://dx.doi.org/10.1136/jitc-2021-004384

Ejemplares similares

IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma
por: Weber, Rebekka, et al.
Publicado: (2020)

HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling
por: Arkhypov, Ihor, et al.
Publicado: (2022)

Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs
por: Lepper, Alisa, et al.
Publicado: (2023)

Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2
por: Özbay Kurt, Feyza Gül, et al.
Publicado: (2022)

Immunosuppressive capacity of circulating MDSC predicts response to immune checkpoint inhibitors in melanoma patients
por: Petrova, Vera, et al.
Publicado: (2023)

Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target
por: Ozbay Kurt, Feyza Gul, et al.
Publicado: (2023)

Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression
por: Groth, Christopher, et al.
Publicado: (2018)

The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression
por: Umansky, Viktor, et al.
Publicado: (2016)

Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
por: Fleming, Viktor, et al.
Publicado: (2018)

Myeloid Cell Modulation by Tumor-Derived Extracellular Vesicles
por: Arkhypov, Ihor, et al.
Publicado: (2020)

G-MDSC-derived exosomes mediate the differentiation of M-MDSC into M2 macrophages promoting colitis-to-cancer transition
por: Wang, Yungang, et al.
Publicado: (2023)

MDSC in Mice and Men: Mechanisms of Immunosuppression in Cancer
por: Vanhaver, Christophe, et al.
Publicado: (2021)

Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma
por: Petrova, Vera, et al.
Publicado: (2020)

MDSC subtypes and CD39 expression on CD8(+) T cells predict the efficacy of anti‐PD‐1 immunotherapy in patients with advanced NSCLC
por: Koh, Jiae, et al.
Publicado: (2020)

Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
por: Weber, Rebekka, et al.
Publicado: (2018)

Critical immunosuppressive effect of MDSC-derived exosomes in the tumor microenvironment
por: Rashid, Mohammad H., et al.
Publicado: (2021)

Halting Retrograde Transport Excludes ErbB-2 From the Nucleus Abrogating Tumor Growth in Triple Negative Breast Cancer
por: Madera, Santiago, et al.
Publicado: (2021)

Repurposing Napabucasin as an Antimicrobial Agent against Oral Streptococcal Biofilms
por: Kuang, Xinyi, et al.
Publicado: (2020)

Napabucasin Reduces Cancer Stem Cell Characteristics in Hepatocellular Carcinoma
por: Li, Ya, et al.
Publicado: (2020)

The Anticancer Effect of Napabucasin (BBI608), a Natural Naphthoquinone
por: Shao, Zeyang, et al.
Publicado: (2023)

Generation of a novel therapeutic peptide that depletes MDSC in tumor-bearing mice
por: Qin, Hong, et al.
Publicado: (2014)

Blocking Migration of Polymorphonuclear Myeloid-Derived Suppressor Cells Inhibits Mouse Melanoma Progression
por: Groth, Christopher, et al.
Publicado: (2021)

Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast cancer
por: Bai, Fang, et al.
Publicado: (2020)

Long non-coding RNA RUNXOR accelerates MDSC-mediated immunosuppression in lung cancer
por: Tian, Xinyu, et al.
Publicado: (2018)

CHBP induces stronger immunosuppressive CD127(+) M-MDSC via erythropoietin receptor
por: Li, Jiawei, et al.
Publicado: (2021)

GTN Enhances Antitumor Effects of Doxorubicin in TNBC by Targeting the Immunosuppressive Activity of PMN-MDSC
por: Mabrouk, Nesrine, et al.
Publicado: (2023)

Suppression of prostate cancer progression by cancer cell stemness inhibitor napabucasin
por: Zhang, Yiming, et al.
Publicado: (2016)

Corrigendum to “Repurposing Napabucasin as an Antimicrobial Agent against Oral Streptococcal Biofilms”
por: Kuang, Xinyi, et al.
Publicado: (2021)

Process Intensification of a Napabucasin Manufacturing Method Utilizing Microflow Chemistry
por: Usutani, Hirotsugu, et al.
Publicado: (2023)

SUN-910 High Enhancement Washout by CT Imaging Does Not Exclude Pheochromocytoma/Paraganglioma: Review of Two Cases
por: Erenler, Feyza, et al.
Publicado: (2020)

THU499 The Mesenchymal Stem Cells Induce Immunosuppressive Microenvironment In Pituitary Tumors
por: Marrero-Rodríguez, Daniel, et al.
Publicado: (2023)

THU481 Glucocorticoid Regeneration By Tumor Cells Promotes Growth By Enhancing Regulatory T Cell Immunosuppression
por: Taves, Matthew D, et al.
Publicado: (2023)

Inhibition of Nox4‐dependent ROS signaling attenuates prostate fibroblast activation and abrogates stromal‐mediated protumorigenic interactions
por: Sampson, Natalie, et al.
Publicado: (2018)

Thermal Proteome Profiling in Zebrafish Reveals Effects of Napabucasin on Retinoic Acid Metabolism
por: Leijten, Niels M., et al.
Publicado: (2021)

BTK Inhibition Reverses MDSC-Mediated Immunosuppression and Enhances Response to Anti-PDL1 Therapy in Neuroblastoma
por: Ishfaq, Mehreen, et al.
Publicado: (2021)

Independent mechanisms of T cell-suppression by subpopulations of myeloid-derived suppressor cells (MDSC) in tumor-bearing hosts
por: Raber, Patrick L, et al.
Publicado: (2013)

Napabucasin Induces Mouse Bone Loss by Impairing Bone Formation via STAT3
por: Huang, Xiangru, et al.
Publicado: (2021)

CD200 promotes immunosuppression in the pancreatic tumor microenvironment
por: Choueiry, Fouad, et al.
Publicado: (2020)

BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment
por: Liu, Wei, et al.
Publicado: (2022)

THU475 Ovarian Tumor-cell Glucocorticoid Receptor Activity Modulates Cytokine Secretion Promoting Recruitment And Activation of Immunosuppressive Cells Into The Tumor Microenvironment
por: Taya, Manisha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0vh0qeust6tv7i4p35050ikuts